Neuron23 logo

Neuron23 Funding & Investors

South San Francisco, CA

Neuron23™ Inc. is an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases.

neuron23.com

Total Amount Raised: $310,000,000

Neuron23's Investors

Neuron23 Funding Rounds

  • Series D

    $96,500,000

    Series D Investors

    SoftBank Vision Fund
    Redmile Group
    Kleiner Perkins
    HBM Healthcare Investments
    Acorn Bioventures
    Westlake Village BioPartners
    Blue Owl

  • Series C

    $100,000,000

    Series C Investors

    SoftBank Vision Fund
    HBM Healthcare Investments
    Westlake Village BioPartners
    Kleiner Perkins
    HBM Partners
    Redmile Group
    Perceptive Advisors
    Acorn Bioventures
    Cowen
    Surveyor Capital

  • Series A

    $33,500,000

    Series A Investors

    Kleiner Perkins
    Westlake Village BioPartners

  • Series B

    $80,000,000

    Series B Investors

    Redmile Group
    Surveyor Capital
    Cowen
    Acorn Bioventures
    HBM Partners
    Kleiner Perkins
    Westlake Village BioPartners
    Perceptive Advisors
    HBM Healthcare Investments
Funding info provided by Diffbot.